Clinical Trial Update: A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study assessing the safety and effectiveness of intravenous ABBV-CLS-628 in adult participants with autosomal dom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• ABBV-CLS-628

Snippet

Sponsor: AbbVie | Conditions: Autosomal Dominant Polycystic Kidney Disease | Phase 2 | Status: RECRUITING